What is the evidence that tau pathology spreads through prion-like propagation?

Abounit S et al (2016) Tunneling nanotubes: a possible highway in the spreading of tau and other prion-like proteins in neurodegenerative diseases. Prion 10(5):344–351 Adams SJ et al (2010) Three repeat isoforms of tau inhibit assembly of four repeat tau filaments. PLoS One 5(5):e10810 Ahmed Z et al (2014) A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol 127(5):667–683 Alibhai J et al (2016) Distribution of misfolded prion protein seeding activity alone does not predict regions of Neurodegeneration. PLoS Biol 14(11):e1002579 Ambadipudi S et al (2017) Liquid-liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein tau. Nat Commun 8(1):275 Ando K et al (2013) Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains. Acta Neuropathol 125(6):861–878 Ando K et al (2016) Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick's disease. Neurobiol Dis 94:32–43 Andorfer C et al (2003) Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J Neurochem 86(3):582–590 Arendt T, Stieler JT, Holzer M (2016) Tau and tauopathies. Brain Res Bull 126(Pt 3):238–292 Arendt T et al (2003) Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals. J Neurosci 23(18):6972–6981 Asai H et al (2015) Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci 18(11):1584–1593 Audouard E et al (2016) High-molecular-weight paired helical filaments from Alzheimer brain induce seeding of wild-type mouse tau into an argyrophillic 4R tau pathology in vivo. Am J Pathol 186(10):2709–2722 Avila J, Gomez-Ramos A, Bolos M (2015) AD genetic risk factors and tau spreading. Front Aging Neurosci 7:99 Berger Z et al (2007) Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J Neurosci 27(14):3650–3662 Bolmont T et al (2007) Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x tau transgenic mice. Am J Pathol 171(6):2012–2020 Braak H et al (1986) Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 65(3):351–355 Brion JP, Tremp G, Octave JN (1999) Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. Am J Pathol 154(1):255–270 Brion JP et al (1985) Mise en évidence immunologique de la protéine tau au niveau des lésions de dégénérescence neurofibrillaire de la maladie d'Alzheimer. ArchBiol(Brux) 95:229–235 Buée L et al (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33(1):95–130 Bussière T et al (1999) Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration. Acta Neuropathol 97(3):221–230 Calafate S et al (2015) Synaptic contacts enhance cell-to-cell tau pathology propagation. Cell Rep 11(8):1176–1183 Castillo-Carranza DL et al (2014) Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds. J Alzheimers Dis 40(Suppl 1):S97–S111 Chapuis J et al (2013) Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry 18(11):1225–1234 Chirita CN et al (2005) Triggers of full-length tau aggregation: a role for partially folded intermediates. Biochemistry 44(15):5862–5872 Clavaguera F et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11(7):909–913 Clavaguera F et al (2013) Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci U S A 110(23):9535–9540 Clavaguera F et al (2014) Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice. Acta Neuropathol 127(2):299–301 Clavaguera F et al (2015) Invited review: Prion-like transmission and spreading of tau pathology. Neuropathol Appl Neurobiol 41(1):47–58 Collinge J (2016) Mammalian prions and their wider relevance in neurodegenerative diseases. Nature 539(7628):217–226 Cook C et al (2014) Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance. Hum Mol Genet 23(1):104–116 Cowan CM, Mudher A (2013) Are tau aggregates toxic or protective in tauopathies? Front Neurol 4:114 Cowan CM et al (2010) Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo. Acta Neuropathol 120(5):593–604 Cowan CM et al (2015) Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers. Sci Rep 5:17191 Croft CL et al (2017) Membrane association and release of wild-type and pathological tau from organotypic brain slice cultures. Cell Death Dis 8(3):e2671 Crowther RA, Goedert M (2000) Abnormal tau-containing filaments in neurodegenerative diseases. J Struct Biol 130(2–3):271–279 de Calignon A et al (2012) Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73(4):685–697 Despres C et al (2017) Identification of the tau phosphorylation pattern that drives its aggregation. Proc Natl Acad Sci U S A 114(34):9080–9085 Dourlen P et al (2017) Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of tau pathology. Mol Psychiatry 22(6):874–883 Dujardin S, Colin M, Buée L (2015) Invited review: animal models of tauopathies and their implications for research/translation into the clinic. Neuropathol Appl Neurobiol 41(1):59–80 Dujardin S et al (2014a) Neuron-to-neuron wild-type tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies. Acta Neuropathol Commun 2:14 Dujardin S et al (2014b) Ectosomes: a new mechanism for non-exosomal secretion of tau protein. PLoS One 9(6):e100760 Duyckaerts C et al (1997) Dissociation of Alzheimer type pathology in a disconnected piece of cortex. Acta Neuropathol 93(5):501–507 Eisele YS, Duyckaerts C (2016) Propagation of Abeta pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131(1):5–25 Espuny-Camacho I et al (2017) Hallmarks of Alzheimer's disease in stem-cell-derived human neurons transplanted into mouse brain. Neuron 93(5):1066–1081 e8 Falcon B et al (2015) Conformation determines the seeding potencies of native and recombinant tau aggregates. J Biol Chem 290(2):1049–1065 Fitzpatrick AWP et al (2017) Cryo-EM structures of tau filaments from Alzheimer's disease. Nature 547(7662):185-190 Funk KE et al (2014) Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity. Biochem J 462(1):77–88 Furman JL et al (2017) Widespread tau seeding activity at early Braak stages. Acta Neuropathol 133(1):91–100 Gamblin TC et al (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci U S A 100(17):10032–10037 Ghetti B et al (2015) Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol Appl Neurobiol 41(1):24–46 Gilley J et al (2012) Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a “P301L” tau knockin mouse. Neurobiol Aging 33(3):621–6e1 -621 e15 Gilley J et al (2016) Mislocalization of neuronal tau in the absence of tangle pathology in phosphomutant tau knockin mice. Neurobiol Aging 39:1–18 Goedert M (2016) The ordered assembly of tau is the gain-of-toxic function that causes human tauopathies. Alzheimers Dement 12(10):1040–1050 Goedert M, Eisenberg DS, Crowther RA (2017) Propagation of tau aggregates and neurodegeneration. Annu Rev Neurosci 40:189–210 Goedert M, Spillantini MG (2017) Propagation of tau aggregates. Mol Brain 10(1):18 Goedert M et al (1988) Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci U S A 85(11):4051–4055 Goedert M et al (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3(4):519–526 Goedert M et al (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383(6600):550–553 Gomez-Ramos A et al (2008) Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells. Mol Cell Neurosci 37(4):673–681 Gomez-Ramos A et al (2009) Characteristics and consequences of muscarinic receptor activation by tau protein. Eur Neuropsychopharmacol 19(10):708–717 Gorlovoy P et al (2009) Accumulation of tau induced in neurites by microglial proinflammatory mediators. FASEB J 23(8):2502–2513 Götz J et al (1995) Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J 14(7):1304–1313 Götz J J et al (2001) Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293(5534):1491–1495 Guo JL et al (2013) Distinct alpha-synuclein strains differentially promote tau inclusions in neurons. Cell 154(1):103–117 Guo JL et al (2016) Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice. J Exp Med 213(12):2635–2654 Guo T, Noble W, Hanger DP (2017) Roles of tau protein in health and disease. Acta Neuropathol 133(5):665–704 Hasegawa M et al (1996) Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein. FEBS Lett 384(1):25–30 Hasegawa M et al (1997) Alzheimer-like changes in microtubule-associated protein tau induced by sulfated glycosaminoglycans. J Biol Chem 272(52):33118–33124 Héraud C et al (2014) Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice. Neurobiol Dis 62:100–112 Höglinger GU et al (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 43(7):699–705 Holmes BB et al (2013) Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc Natl Acad Sci U S A 110(33):E3138–E3147 Holmes BB et al (2014) Proteopathic tau seeding predicts tauopathy in vivo. Proc Natl Acad Sci U S A 111(41):E4376–E4385 Hu W et al (2016) Hyperphosphorylation determines both the spread and the morphology of tau pathology. Alzheimers Dement 12(10):1066–1077 Hutton M et al (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393(6686):702–705 Iba M et al (2013) Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy. J Neurosci 33(3):1024–1037 Iba M et al (2015) Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections. Acta Neuropathol 130(3):349–362 Irwin DJ et al (2012) Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Brain 135(Pt 3):807–818 Irwin DJ et al (2013) Acetylated tau neuropathology in sporadic and hereditary tauopathies. Am J Pathol 183(2):344–351 Jackson SJ et al (2016) Short fibrils constitute the major species of seed-competent tau in the brains of mice transgenic for human P301S tau. J Neurosci 36(3):762–772 Jaunmuktane Z et al (2015) Evidence for human transmission of amyloid-beta pathology and cerebral amyloid angiopathy. Nature 525(7568):247–250 Kampers T et al (1996) RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett 399(3):344–349 Karch CM, Jeng AT, Goate AM (2012) Extracellular tau levels are influenced by variability in tau that is associated with tauopathies. J Biol Chem 287(51):42751–42762 Kaufman SK et al (2016) Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo. Neuron 92(4):796–812 Kaufman SK et al (2017) Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue. Acta Neuropathol Commun 5(1):41 Kovacs GG (2016) Molecular pathological classification of neurodegenerative diseases: Turning towards precision medicine. Int J Mol Sci 17(2):E189 Kovacs GG (2015) Invited review: neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol 41(1):3–23 Lasagna-Reeves CA et al (2011) Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol Neurodegener 6:39 Lasagna-Reeves CA et al (2012) Identification of oligomers at early stages of tau aggregation in Alzheimer's disease. FASEB J 26(5):1946–1959 Le Guennec, K., et al., 17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression. Mol Psychiatry 22(8):1119–1125 Lewis J et al (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293(5534):1487–1491 Liu L et al (2012) Trans-synaptic spread of tau pathology in vivo. PLoS One 7(2):e31302 Matsuo ES et al (1994) Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 13(4):989–1002 Mirbaha H et al (2015) Tau trimers are the minimal propagation unit spontaneously internalized to seed intracellular aggregation. J Biol Chem 290(24):14893–14903 Mohamed NV, Desjardins A, Leclerc N (2017) Tau secretion is correlated to an increase of Golgi dynamics. PLoS One 12(5):e0178288 Moreau K et al (2014) PICALM modulates autophagy activity and tau accumulation. Nat Commun 5:4998 Morris M et al (2015) Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice. Nat Neurosci 18(8):1183–1189 Mudher A et al (2004) GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol Psychiatry 9(5):522–530 Mudher AK et al (1999) Induction of hyperphosphorylated tau in living slices of rat hippocampal formation and subsequent detection using an ELISA. J Neurosci Methods 88(1):15–25 Nobuhara CK et al (2017) Tau antibody targeting pathological species blocks neuronal uptake and interneuron propagation of tau in vitro. Am J Pathol 187(6):1399–1412 Ozcelik S et al (2016) Co-expression of truncated and full-length tau induces severe neurotoxicity. Mol Psychiatry 21(12):1790–1798 Pearce MM et al (2015) Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain. Nat Commun 6:6768 Peeraer E et al (2015) Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice. Neurobiol Dis 73:83–95 Perez M et al (1996) Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. J Neurochem 67(3):1183–1190 Planel E et al (2007) Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci 27(12):3090–3097 Plouffe V et al (2012) Hyperphosphorylation and cleavage at D421 enhance tau secretion. PLoS One 7(5):e36873 Polanco JC et al (2016) Extracellular vesicles isolated from the brains of rTg4510 mice seed tau protein aggregation in a threshold-dependent manner. J Biol Chem 291(24):12445–12466 Pooler AM et al (2013) Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep 14(4):389–394 Pooler AM et al (2015) Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease. Acta Neuropathol Commun 3:14 Reynolds MR et al (2006) Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies. J Neurosci 26(42):10636–10645 Rodriguez L et al (2017) Rab7A regulates tau secretion. J Neurochem 141(4):592–605 Saijo E et al (2017) Ultrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluid. Acta Neuropathol 133(5):751–765 Sanders DW et al (2014) Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82(6):1271–1288 Sankaranarayanan S et al (2015) Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models. PLoS One 10(5):e0125614 Santacruz K et al (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309(5733):476–481 Schneider A et al (1999) Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry 38(12):3549–3558 Scott JR, Davies D, Fraser H (1992) Scrapie in the central nervous system: neuroanatomical spread of infection and Sinc control of pathogenesis. J Gen Virol 73(Pt 7):1637–1644 Seubert P et al (1995) Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J Biol Chem 270(32):18917–18922 Shi Y et al (2017) ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549(7673):523–527 Simon D et al (2012) Proteostasis of tau. Tau overexpression results in its secretion via membrane vesicles. FEBS Lett 586(1):47–54 Spillantini MG et al (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci U S A 95(13):7737–7741 Spires-Jones TL, Attems J, Thal DR ( 2017) Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol 134(2):187–205 Spires-Jones TL et al (2011) Are tangles as toxic as they look? J Mol Neurosci 45(3):438–444 Spittaels K et al (1999) Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol 155(6):2153–2165 Stancu IC et al (2015) Templated misfolding of tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in tau transgenic mice. Acta Neuropathol 129(6):875–894 Takahashi M et al (2015) Extracellular association of APP and tau fibrils induces intracellular aggregate formation of tau. Acta Neuropathol 129(6):895–907 Takeda S et al (2016) Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients. Ann Neurol 80(3):355–367 Taniguchi-Watanabe S et al (2016) Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau. Acta Neuropathol 131(2):267–280 Tardivel M et al (2016) Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological tau protein assemblies. Acta Neuropathol Commun 4(1):117 Thal DR et al (2002) Phases of Abeta-deposition in the human brain and its relevance for the development of AD. Neurology 58(12):1791–1800 Thomas SN et al (2012) Dual modification of Alzheimer's disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach. Acta Neuropathol 123(1):105–117 Uchihara T (2007) Silver diagnosis in neuropathology: principles, practice and revised interpretation. Acta Neuropathol 113(5):483–499 Van Cauwenberghe C, Van Broeckhoven C, Sleegers K (2016) The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med 18(5):421–430 Vasconcelos B et al (2016) Heterotypic seeding of tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of tau-pathology in vivo. Acta Neuropathol 131:549 von Bergen M et al (2000) Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. Proc Natl Acad Sci U S A 97(10):5129–5134 Walsh DM, Selkoe DJ (2016) A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration. Nat Rev Neurosci 17(4):251–260 Wang Y et al (2017) The release and trans-synaptic transmission of tau via exosomes. Mol Neurodegener 12(1):5 Wegmann S et al (2015) Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity. EMBO J 34(24):3028–3041 Wilson DM, Binder LI (1997) Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am J Pathol 150(6):2181–2195 Wischik CM et al (1988) Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A 85(13):4884–4888 Wittmann CW et al (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293(5530):711–714 Wray S et al (2008) Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats. J Neurochem 105(6):2343–2352 Wu JW et al (2016) Neuronal activity enhances tau propagation and tau pathology in vivo. Nat Neurosci 19(8):1085–1092 Yamada K et al (2011) In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice. J Neurosci 31(37):13110–13117 Yamada K et al (2014) Neuronal activity regulates extracellular tau in vivo. J Exp Med 211(3):387–393 Yanamandra K et al (2013) Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron 80(2):402–414 Yetman MJ et al (2016) Transgene expression in the Nop-tTA driver line is not inherently restricted to the entorhinal cortex. Brain Struct Funct 221(4):2231–2249 Zhang X et al (2017) RNA stores tau reversibly in complex coacervates. PLoS Biol 15(7):e2002183 Zhao N et al (2017) Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes. Neuron 96(1):115–129 e5 Zhong Q et al (2012) Tau isoform composition influences rate and extent of filament formation. J Biol Chem 287(24):20711–20719 Zilka N et al (2012) The self-perpetuating tau truncation circle. Biochem Soc Trans 40(4):681–686